Evidence map›Paper›PMID 39195958›Full record

ArticleNature cardiovascular research2023

Efficient megakaryopoiesis and platelet production require phospholipid remodeling and PUFA uptake through CD36.

Maria N Barrachina, Gerard Pernes, Isabelle C Becker, Isabelle Allaeys, Thomas I Hirsch, Dafna J Groeneveld, Abdullah O Khan, Daniela Freire, Karen Guo, Estelle Carminita and 13 more

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. miR-146a mimic therapy protects against platelet-mediated thrombosis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  3. Article
  4. Laboratory Assessment and Clinical Outlook forAnnals of laboratory medicine · 2026
    Review
  5. Article
  6. Platelet Disorders and Medication Strategies.Thrombosis and haemostasis · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Lipid Metabolism and Immune Function: Chemical Tools for Insights into T-Cell Biology.Chembiochem : a European journal of chemical biology · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Maria N BarrachinaVascular Biology Program, Boston Children's Hospital, Boston, MA, USA.
Gerard PernesHaematopoiesis and Leukocyte Biology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.ORCID 0000-0001-6524-3255
Isabelle C BeckerVascular Biology Program, Boston Children's Hospital, Boston, MA, USA.
Isabelle AllaeysCentre de Recherche du CHU de Québec-Université Laval and Centre de Recherche ARThrite, Québec, QC, Canada.ORCID 0000-0003-4697-046X
Thomas I HirschVascular Biology Program, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-1373-2388
Dafna J GroeneveldDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA.
Abdullah O KhanInstitute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Daniela FreireVascular Biology Program, Boston Children's Hospital, Boston, MA, USA.
Karen GuoVascular Biology Program, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0001-9455-348X
Estelle CarminitaVascular Biology Program, Boston Children's Hospital, Boston, MA, USA.
Pooranee K MorganHaematopoiesis and Leukocyte Biology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Thomas J C CollinsHaematopoiesis and Leukocyte Biology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.ORCID 0000-0002-8044-2815
Natalie A MellettMetabolomics, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Zimu WeiDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA.
Ibrahim AlmazniInstitute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Joseph E ItalianoVascular Biology Program, Boston Children's Hospital, Boston, MA, USA.
James LuyendykDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA.
Peter J MeikleMetabolomics, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.ORCID 0000-0002-2593-4665
Mark PuderVascular Biology Program, Boston Children's Hospital, Boston, MA, USA.
Neil V MorganInstitute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Eric BoilardCentre de Recherche du CHU de Québec-Université Laval and Centre de Recherche ARThrite, Québec, QC, Canada.ORCID 0000-0001-6319-6432
Andrew J MurphyHaematopoiesis and Leukocyte Biology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.ORCID 0000-0001-7039-7777
Kellie R MachlusVascular Biology Program, Boston Children's Hospital, Boston, MA, USA. kellie.machlus@childrens.harvard.edu.ORCID 0000-0002-2155-1050

Funding

HARVARD-LONGWOOD RESEARCH TRAINING IN VASCULAR SURGERYT32HL007734 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FERRAN, CHRISTIANE, LOGERFO, FRANK W · 1993 to 2023
$10.5M
The Centrosome as a master controller of platelet production.R35HL161175 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI JOSEPH E ITALIANO · 2022 to 2026
$5.3M
The Biogenesis of Platelet-Derived Extracellular Vesicles and their Impact on Megakaryocyte MaturationR01HL151494 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MACHLUS, KELLIE RAE · 2021 to 2025
$2.9M
Fibrin(ogen) control of metabolic inflammation and obesityR01DK112778 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2019 to 2022
$1.5M
Elucidation of the mechanisms by which fatty acids drive megakaryopoiesisR01DK139341 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Kellie Rae Machlus · 2024 to 2026
$1.1M
The Role of CCL5 in Hematopoietic Stem Cell Activation and SkewingR03DK124746 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI MACHLUS, KELLIE RAE · 2021 to 2022
$266k
American Heart Association (American Heart Association, Inc.) 23POST101143American Society of Hematology (ASH) ASH Restart Award 2021Department of Health | National Health and Medical Research Council (NHMRC) 2009965Deutsche Forschungsgemeinschaft (German Research Foundation) DFG; BE 7766/2-1Fonds de Recherche du Québec - Santé (Fonds de la recherche en sante du Quebec) Senior awardNHLBI NIH HHS R01 HL151494NHLBI NIH HHS R35 HL161175NHLBI NIH HHS T32 HL007734NIDDK NIH HHS R01 DK112778NIDDK NIH HHS R01 DK139341NIDDK NIH HHS R03 DK124746Saudi Arabia Cultural Bureau in London (Royal Embassy of Saudi Arabia Cultural Bureau in London) FellowshipU.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 5T32HL007734U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL151494U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R35HL161175U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK112778U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R03DK124746Wellcome TrustWellcome Trust (Wellcome) 218649/Z/19/Z
6 · The paper itself

Abstract

Lipids contribute to hematopoiesis and membrane properties and dynamics; however, little is known about the role of lipids in megakaryopoiesis. Here we show that megakaryocyte progenitors, megakaryocytes and platelets present a unique lipidome progressively enriched in polyunsaturated fatty acid (PUFA)-containing phospholipids. In vitro, inhibition of both exogenous fatty acid functionalization and uptake as well as de novo lipogenesis impaired megakaryocyte differentiation and proplatelet production. In vivo, mice on a high saturated fatty acid diet had significantly lower platelet counts, which was prevented by eating a PUFA-enriched diet. Fatty acid uptake was largely dependent on CD36, and its deletion in mice resulted in low platelets. Moreover, patients with a CD36 loss-of-function mutation exhibited thrombocytopenia and increased bleeding. Our results suggest that fatty acid uptake and regulation is essential for megakaryocyte maturation and platelet production and that changes in dietary fatty acids may be a viable target to modulate platelet counts.

Indexed as

Blood PlateletsCD36 AntigensFatty Acids, UnsaturatedMegakaryocytesPhospholipidsThrombopoiesisAnimalsCells, CulturedFemaleHumansLipidomicsMaleMegakaryocyte Progenitor CellsMiceMice, Inbred C57BLMice, KnockoutCD36 AntigensCD36 protein, humanCd36 protein, mouseFatty Acids, UnsaturatedPhospholipids

Identifiers

PMID39195958
PMCPMC11909960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.